Advertisement

Permanent contraception: modern approaches justify a new name

  • Jeffrey T. Jensen
    Correspondence
    Corresponding author.
    Affiliations
    Department of Obstetrics & Gynecology, Oregon Health & Science University (OHSU), Portland, OR, USA
    Division of Reproductive and Developmental Sciences, Oregon National Primate Research Center, Beaverton, OR, USA
    Search for articles by this author
      Globally, permanent contraception represents the leading method of family planning for women, particular for those over age 35 [ ]. Although permanent methods are widely available worldwide, they are marginalized and stigmatized in some countries and highly restricted in others. Concerns about reversibility and side effects limit access in some more developed countries, while inadequate availability of surgical facilities and trained personnel presents a significant barrier to use in many developing nations.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Contraception
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. World contraceptive use 2011. Available at: http://www.un.org/esa/population/publications/contraceptive2011/wallchart_front.pdf. (date accessed.

        • Finer L.B.
        • Zolna M.R.
        Unintended pregnancy in the United States: incidence and disparities, 2006.
        Contraception. 2011; 84: 478-485
        • Curtis K.M.
        • Mohllajee A.P.
        • Peterson H.B.
        Regret following female sterilization at a young age: a systematic review.
        Contraception. 2006; 73: 205-210
        • Panel P.
        • Grosdemouge I.
        Predictive factors of Essure implant placement failure: prospective, multicenter study of 495 patients.
        Fertil Steril. 2010; 93: 29-34
        • Hieu D.T.
        • Tan T.T.
        • Tan D.N.
        • Nguyet P.T.
        • Than P.
        • Vinh D.Q.
        31,781 cases of non-surgical female sterilisation with quinacrine pellets in Vietnam.
        Lancet. 1993; 342: 213-217
        • Bhattacharyya S.
        Quinacrine sterilization (QS): the ethical issues.
        Int J Gynaecol Obstet. 2003; 83: S13-S21
        • Sokal D.C.
        • Hieu do T.
        • Loan N.D.
        • et al.
        Safety of quinacrine contraceptive pellets: results from 10-year follow-up in Vietnam.
        Contraception. 2008; 78: 66-72
        • Sokal D.C.
        • Hieu do T.
        • Loan N.D.
        • et al.
        Contraceptive effectiveness of two insertions of quinacrine: results from 10-year follow-up in Vietnam.
        Contraception. 2008; 78: 61-65